Lin stated, "we remain on track to complete the [DRAGON] study in Q4 this year." Lin shared, "the FDA recommended that we complete the 24-month study, which we are about to complete coming up in ...
Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round attracted prominent leaders in AI and ...
Use of Non-GAAP Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback